T3.9 Kilder

Binyrebarksykdommer

Løvås K et al. Primær binyrebarksvikt – årsaker, diagnostikk og behandling. Tidsskr Nor Legeforen 2005; 125: 155-8

Diabetes mellitus

Nasjonal faglig retningslinje for diabetes. https://helsedirektoratet.no/retningslinjer/diabetes

Nasjonal faglig retningslinje for svangerskapsdiabetes. https://www.helsedirektoratet.no/retningslinjer/svangerskapsdiabetes

Diabetisk ketoacidose. https://www.endokrinologi.no/

Fedme

NICE: Obesity: identification, assessment and management. Sist oppdatert 08.09.2022.

NICE: Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends. 8. April 2022.

Obesity in adults: a clinical practice guideline. CMAJ August 04, 2020 192 (31) E875-E891; DOI: https://doi.org/10.1503/cmaj.191707

Semlitsch T, Stiegler FL et al. Management of overweight and obesity in primary care—A systematic overview of international evidence-based guidelines. https://doi.org/10.1111/obr.12889

European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care. Obes Facts 2019;12:40–66 https://doi.org/10.1159/000496183

Tak, Y.J., Lee, S.Y. Long-Term Efficacy and Safety of Anti-Obesity Treatment: Where Do We Stand?. Curr Obes Rep 10, 14–30 (2021). https://doi.org/10.1007/s13679-020-00422-w

BMJ Best Practice. Obesity in adults. Treatment algorithm.

Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes. JAMA. 2022;327(2):138-150. doi:10.1001/jama.2021.23619

UpToDate. Obesity in adult. Drug therapy. Sist oppdatert 6. oktober 2022. Phentermine-topiramate.

Nye Metoder: Setmelanotide (Imcivree) ID2021_012.

Hjelmesæth JS, Lund RS, Sagen JV, Valderhaug TG. Vektreduserende medisiner – for hvem, hvordan, hvor lenge? Tidsskr Nor Legeforen 2022 doi: 10.4045/tidsskr.22.0115.

Rolin J, Ødegård RA, Amundsen VV, Köpp UMS, Kokkvoll A, Júlíusson RB, Hjelmesæth JS. Medikamentell tilleggsbehandling for vektreduksjon hos ungdom med alvorlig fedme Tidsskr Nor Legeforen 2022 doi: 10.4045/tidsskr.22.0540.

Hypofysesykdommer

Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007; 356(1): 39-46.

Schade R, Andersohn F, Suissa S, Haverkamp W, Garbe E. Dopamine agonists and the risk of cardiacvalve regurgitation. N Engl J Med 2007; 356(1): 29-38.

Molitch ME. The cabergoline-resistant prolactinoma patient: new challenges. J Clin Endocrinol Metab 2008; 93(12): 4643-5.

Bevan JS, Atkin SL, Atkinson AB et al. Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insuline-like growth factor-I, and tumor size. J. Clin Endocrinol Metab 2002; 87(10): 4554-63.

Carlsen SM, Lund-Johansen M, Schreiner T et al. Preoperative octreotide treatment in newly diagnosed acromegalic patients with mecroadenomas increases cure short-term postoperative rates: a prospective, randomized trial. J Clin Endocrinol Metab 2008; 93(8): 2984-90.

Clayton JA, Le J, I, Hall IP. Severe hyponatraemia in medical in-patients: aetiology, assessment and outcome. QJM 2006; 99(8): 505-511.

Mannlige gonadefunksjonsforstyrrelser

Corona G., et al., European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males. Andrology, 2020

Paratyreoideasykdommer

Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 9th Edition, (Belezikian JP Editor, Wiley-Blackwell, Hoboken, NJ, USA 2018.

Eriksen EF Osteoporose og forstyrrelser i kalsiummetabolismen kapittel 20 i Inremedisin (Birkeland KI, Gullestad L, Aabakken L eds.); Vett og Viten, Oslo, 2017

Bilezikian JP, Brandi ML, Wastell R et al. Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop The Journal of Clinical Endocrinology & Metabolism, 99 (10); 2014:3561–3569,

Bollerslev J, Rejnmark L, Marcocci C et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. European Society of Endocrinology. Eur J Endocrinol. 2015;173(2):G1-20.

Pretorius, M., et al., Mortality and Morbidity in Mild Primary Hyperparathyroidism: Results From a 10-Year Prospective Randomized Controlled Trial of Parathyroidectomy Versus Observation. Ann Intern Med, 2022. 2.

Pretorius, M., et al., Effects of Parathyroidectomy on Quality of Life: 10 Years of Data From a Prospective Randomized Controlled Trial on Primary Hyperparathyroidism (the SIPH-Study). J Bone Miner Res, 2021. 36(1): p. 3-11. 

Tyreoideasykdommer

Nasjonal veileder i Endokrinologi 

Nasjonalt handlingsprogram med retningslinjer for utredning, behandling og oppfølgning av kreft i skjoldbruskkjertelen. IS 2478 

European Thyroid Association – ETA Guidelines https://www.eurothyroid.com/guidelines/eta_guidelines.html 

American Thyroid Assocoatipon – ATA Guidelines https://www.thyroid.org/professionals/ata-professional-guidelines/ 

ATA – Guidelines. Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Alexander, Pearce, et al., Thyroid. March 2017, 27(3): 315-389. doi:10.1089/thy.2016.0457. 

ATA - Guidelines Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Ross, Burch, et al., Thyroid. Oct 2016, 26(10): 1343-1421. 

ATA – Guidelines Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) Jonklaas, Bianco, et al., Thyroid 24(12): 1670-1751, 2014 

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Haugen, Alexander, et al., Thyroid. Jan 2016, 26(1): 1-133. 

ETA Guidelines 2012 The Use of L-T4 + L-T3 in the Treatment of HypothyroidismWiersinga W.M.a · Duntas L.b · Fadeyev V.c · Nygaard B.d · Vanderpump M.P.J.e 

European Thyroid Association Guidelines 2014for the Management of Subclinical Hypothyroidism in Pregnancy and in Children Lazarus J.a · Brown R.S.c · Daumerie C.d · Hubalewska-Dydejczyk A.e · Negro R.f · Vaidya B.b 

ETA Guidelines 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy Bartalena L.a · Baldeschi L.b · Boboridis K.c · Eckstein A.d · Kahaly G.J.e · Marcocci C.f · Perros P.g · Salvi M.h · Wiersinga W.M.i · on behalf of the European Group on Graves'' Orbitopathy (EUGOGO) 

European Thyroid Journal 2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism Kahaly G.J.a · Bartalena L.b · Hegedüs L.c · Leenhardt L.d · Poppe K.e · Pearce S.H.f 

HUNT undersøkelsene i NordTrøndelag 

Changes in the prevalence og hypothyroidism: HUNT Study in Norway. Bjørn Olav Åsvold, Lars Vatten and Trine Bjøro. Eur Jour of Endocrinology 2013; 169: 613-20. 

Anders Svare Disputert mars 2014 Sammenheng mellom stoffskifte og beintetthet/brudd, og mellom stoffskifte og vektendring. Data fra HUNT2 og 3.